GSE48812 11 V 6 SULFORAPHANE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE48812 11 V 6 SULFORAPHANE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE48812 11 V 6 SULFORAPHANE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE48812 11 V 6 SULFORAPHANE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE48812 11 V 6 SULFORAPHANE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

thymosin beta 15C

Gene

WNK lysine deficient protein kinase 4

Gene

carnitine palmitoyltransferase 1C

Gene

Ras association domain family member 8

Gene

ankyrin repeat and LEM domain containing 2

Gene

gem nuclear organelle associated protein 5

Gene

RIO kinase 1

Gene

exocyst complex component 6B

Gene

FCH and mu domain containing endocytic adaptor 1

Gene

vascular endothelial zinc finger 1

  • Gene

    thymosin beta 15C


  • Gene

    WNK lysine deficient protein kinase 4


  • Gene

    carnitine palmitoyltransferase 1C


  • Gene

    Ras association domain family member 8


  • Gene

    ankyrin repeat and LEM domain containing 2


  • Gene

    gem nuclear organelle associated protein 5



  • Gene

    exocyst complex component 6B


  • Gene

    FCH and mu domain containing endocytic adaptor 1


  • Gene

    vascular endothelial zinc finger 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.